Document Basket

Saved pages

Saved documents

Please note: This information is saved in a cookie. In case your browser deletes cookies after a session, the information will be lost.

DKSH to further drive sales growth for Cheplapharm in seven Asian markets January 09, 2018


			
				DKSH to further drive sales growth for Cheplapharm in seven Asian markets

DKSH, the leading Market Expansion Services provider with a focus on Asia, and Cheplapharm Arzneimittel GmbH, a German family-owned pharmaceutical company that offers branded products globally, have signed a deal to drive sales growth for its business in seven Asian markets.

Media release

DKSH to further drive sales growth for Cheplapharm in seven Asian markets

DKSH, the leading Market Expansion Services provider with a focus on Asia, and Cheplapharm Arzneimittel GmbH, a German family-owned pharmaceutical company that offers branded products globally, have signed a deal to drive sales growth for its business in seven Asian markets.

Bangkok, Thailand, January 9, 2018 – DKSH Business Unit Healthcare, a leading Market Expansion Services provider for healthcare companies seeking to grow their business in Asia, has started a collaboration with Cheplapharm to renew sales growth of its branded products across Asia.

 

DKSH will provide marketing, sales, distribution and logistics services for the products across pharmacies, hospitals and clinics in Thailand, Malaysia, Singapore, Myanmar, Cambodia, Hong Kong and Macau. In this way DKSH will support Cheplapharm in renewing growth for their established products.

 

“We selected DKSH for the company’s extensive experience managing sales and distributing products across Asia. Their extensive network across healthcare decision makers will help us make our products available for people who need it. We are impressed by and value DKSH’s experience and expertise in the region and are looking forward to mutually develop and foster a trustful and professional partnership with our new business partners,” said Edeltraud Lafer, Chief Operating Officer of Cheplapharm.

 

“Our in-depth knowledge of the local markets and well-established distribution network across Asia allows us to provide regional solutions and duplicate success across markets. With the largest dedicated salesforce in Asia and an unwavering commitment to quality and compliance, we are keen to increase sales for our new partner Cheplapharm,” said Bijay Singh, Head, Business Unit Healthcare, DKSH.